Renewal of Department of Defense Federal Advisory Committees, 35126 [E8-13992]

Download as PDF 35126 Federal Register / Vol. 73, No. 120 / Friday, June 20, 2008 / Notices REASON: employees, shall be appointed as experts and consultants under the authority of 5 U.S.C. 3109 and with the exception of travel and per diem for official travel, shall serve without compensation, unless otherwise authorized by the Secretary of Defense. The Secretary of Defense shall renew the appointments of these Special Government Employees on an annual basis. The Under Secretary of Defense (Personnel and Readiness) or designed representative shall select the Panel’s Chairperson from the total Panel membership. The Panel shall be authorized to establish subcommittees, as necessary and consistent with its mission, and these subcommittees or working groups shall operate under the provisions of the Federal Advisory Committee Act of 1972, the Government in the Sunshine Act of 1976, and other appropriate federal regulations. Such subcommittees or workgroups shall not work independently of the chartered Panel, and shall report all their recommendations and advice to the Panel for full deliberation and discussion. Subcommittees or workgroups have no authority to make decisions on behalf of the chartered Panel nor can they report directly to the Department of Defense or any federal officers or employees who are not Panel members. FOR FURTHER INFORMATION CONTACT: Contact Jim Freeman, Deputy Committee Management Officer for the Department of Defense, 703–601–6128. SUPPLEMENTARY INFORMATION: The Panel shall meet at the call of the Panel’s Designated Federal Officer, in consultation with the Panel’s chairperson. The Designated Federal Officer, pursuant to DoD policy, shall be a full-time or permanent part-time DoD employee, and shall be appointed in accordance with established DoD policies and procedures. The Designated Federal Officer or duly appointed Alternate Designated Federal Officer shall attend all Panel meetings and subcommittee meetings. Pursuant to 41 CFR 102–3.105(j) and 102–3.140, the public or interested organizations may submit written statements to the Uniform Formulary Beneficiary Advisory Panel membership about the Panel’s mission and functions. Written statements may be submitted at any time or in response to the stated agenda of planned meeting of the Uniform Formulary Beneficiary Advisory Panel. All written statements shall be submitted to the Designated Federal Officer for the Uniform Formulary The NSA Archives were set up to maintain historical information on NSA/CSS activities and does not maintain personal information about individuals. The information stored in the NSA Archives is indexed and routinely retrieved by subject matter. While the databases that contain the Archived information have the capability to do a keyword search on names, this type of search is rarely done. [FR Doc. E8–13995 Filed 6–19–08; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Office of the Secretary of Defense Renewal of Department of Defense Federal Advisory Committees Department of Defense. Notice. AGENCY: ACTION: Under the provisions of the Federal Advisory Committee Act of 1972, (5 U.S.C. Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.65, the Department of Defense gives notice that it is renewing the charter for the Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as the Panel). The Panel is a non-discretionary federal advisory committee established by the Secretary of Defense to provide the Department of Defense, the Assistant Secretary of Defense (Health Affairs) and the Director, TRICARE Management Activity independent advice and recommendations on the development of the uniform formulary. The Panel, in accomplishing its mission: (a) Creates transparency in the policy decisions regarding the DoD Uniform Formulary; (b) provides public forum where beneficiaries may voice their opinions regarding formulary changes allowing panel members, who represent their interests, to advocate for change within their member organizations and beyond. The Panel shall be composed of not more than 15 members, who shall include members that represent (a) NonGovernment organizations and associations that represent the views and interests of a large number of eligible covered beneficiaries; (b) contractors responsible for the TRICARE retail pharmacy program; (c) contractors responsible for the national mail-order pharmacy program; and (d) TRICARE network providers. Panel members appointed by the Secretary of Defense, who are not federal officers or jlentini on PROD1PC65 with NOTICES SUMMARY: VerDate Aug<31>2005 16:53 Jun 19, 2008 Jkt 214001 PO 00000 Frm 00011 Fmt 4703 Sfmt 4703 Beneficiary Advisory Panel, and this individual will ensure that the written statements are provided to the membership for their consideration. Contact information for the Uniform Formulary Beneficiary Advisory Panel’s Designated Federal Officer can be obtained from the GSA’s FACA Database—https://www.fido.gov/ facadatabase/public.asp. The Designated Federal Officer, pursuant to 41 CFR 102–3.150, will announce planned meetings of the Uniform Formulary Beneficiary Advisory Panel. The Designated Federal Officer, at that time, may provide additional guidance on the submission of written statements that are in response to the stated agenda for the planned meeting in question. Dated: June 16, 2008. Patricia L. Toppings, OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. E8–13992 Filed 6–19–08; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Office of the Secretary [Docket ID: DoD–2008–OS–0072] U.S. Court of Appeals for the Armed Forces Proposed Rules Change Notice of Proposed Change to the Rules of Practice and Procedure of the United States Court of Appeals for the Armed Forces. ACTION: SUMMARY: This notice announces the following proposed change to Rule 21(f) of the Rules of Practice and Procedure, United States Court of Appeals for the Armed Forces for public notice and comment. New language is in bold print. Language to be removed is within brackets. DATES: Comments on the proposed change must be received within 30 days of the date of this notice. ADDRESSES: You may submit comments, identified by docket number and/or Regulatory Information Number (RIN) and title by any of the following methods: • Federal eRulemaking Portal: http:// www.regulations.gov. Follow the instructions for submitting comments. • Mail: Federal Docket Management System Office, 1160 Defense Pentagon, Washington, DC 20301–1160. Instructions: All submissions received must include the agency name and docket number or RIN for this Federal Register document. The general policy for comments and other submissions E:\FR\FM\20JNN1.SGM 20JNN1

Agencies

[Federal Register Volume 73, Number 120 (Friday, June 20, 2008)]
[Notices]
[Page 35126]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-13992]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary of Defense


Renewal of Department of Defense Federal Advisory Committees

AGENCY: Department of Defense.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Under the provisions of the Federal Advisory Committee Act of 
1972, (5 U.S.C. Appendix, as amended), the Government in the Sunshine 
Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.65, the 
Department of Defense gives notice that it is renewing the charter for 
the Uniform Formulary Beneficiary Advisory Panel (hereafter referred to 
as the Panel).
    The Panel is a non-discretionary federal advisory committee 
established by the Secretary of Defense to provide the Department of 
Defense, the Assistant Secretary of Defense (Health Affairs) and the 
Director, TRICARE Management Activity independent advice and 
recommendations on the development of the uniform formulary. The Panel, 
in accomplishing its mission: (a) Creates transparency in the policy 
decisions regarding the DoD Uniform Formulary; (b) provides public 
forum where beneficiaries may voice their opinions regarding formulary 
changes allowing panel members, who represent their interests, to 
advocate for change within their member organizations and beyond.
    The Panel shall be composed of not more than 15 members, who shall 
include members that represent (a) Non-Government organizations and 
associations that represent the views and interests of a large number 
of eligible covered beneficiaries; (b) contractors responsible for the 
TRICARE retail pharmacy program; (c) contractors responsible for the 
national mail-order pharmacy program; and (d) TRICARE network 
providers. Panel members appointed by the Secretary of Defense, who are 
not federal officers or employees, shall be appointed as experts and 
consultants under the authority of 5 U.S.C. 3109 and with the exception 
of travel and per diem for official travel, shall serve without 
compensation, unless otherwise authorized by the Secretary of Defense. 
The Secretary of Defense shall renew the appointments of these Special 
Government Employees on an annual basis. The Under Secretary of Defense 
(Personnel and Readiness) or designed representative shall select the 
Panel's Chairperson from the total Panel membership.
    The Panel shall be authorized to establish subcommittees, as 
necessary and consistent with its mission, and these subcommittees or 
working groups shall operate under the provisions of the Federal 
Advisory Committee Act of 1972, the Government in the Sunshine Act of 
1976, and other appropriate federal regulations.
    Such subcommittees or workgroups shall not work independently of 
the chartered Panel, and shall report all their recommendations and 
advice to the Panel for full deliberation and discussion. Subcommittees 
or workgroups have no authority to make decisions on behalf of the 
chartered Panel nor can they report directly to the Department of 
Defense or any federal officers or employees who are not Panel members.

FOR FURTHER INFORMATION CONTACT: Contact Jim Freeman, Deputy Committee 
Management Officer for the Department of Defense, 703-601-6128.

SUPPLEMENTARY INFORMATION: The Panel shall meet at the call of the 
Panel's Designated Federal Officer, in consultation with the Panel's 
chairperson. The Designated Federal Officer, pursuant to DoD policy, 
shall be a full-time or permanent part-time DoD employee, and shall be 
appointed in accordance with established DoD policies and procedures. 
The Designated Federal Officer or duly appointed Alternate Designated 
Federal Officer shall attend all Panel meetings and subcommittee 
meetings.
    Pursuant to 41 CFR 102-3.105(j) and 102-3.140, the public or 
interested organizations may submit written statements to the Uniform 
Formulary Beneficiary Advisory Panel membership about the Panel's 
mission and functions. Written statements may be submitted at any time 
or in response to the stated agenda of planned meeting of the Uniform 
Formulary Beneficiary Advisory Panel.
    All written statements shall be submitted to the Designated Federal 
Officer for the Uniform Formulary Beneficiary Advisory Panel, and this 
individual will ensure that the written statements are provided to the 
membership for their consideration. Contact information for the Uniform 
Formulary Beneficiary Advisory Panel's Designated Federal Officer can 
be obtained from the GSA's FACA Database--https://www.fido.gov/
facadatabase/public.asp.
    The Designated Federal Officer, pursuant to 41 CFR 102-3.150, will 
announce planned meetings of the Uniform Formulary Beneficiary Advisory 
Panel. The Designated Federal Officer, at that time, may provide 
additional guidance on the submission of written statements that are in 
response to the stated agenda for the planned meeting in question.

    Dated: June 16, 2008.
Patricia L. Toppings,
OSD Federal Register Liaison Officer, Department of Defense.
 [FR Doc. E8-13992 Filed 6-19-08; 8:45 am]
BILLING CODE 5001-06-P